Hangzhou, China - Recently, MicroPort® Orthopedics attended the 11th Annual Meeting of Chinese Association of Orthpaedic Surgeons ("CAOS 2018") that focused on industries of joint, spine, trauma, and sport medicine. Several orthopedic experts specialized in minimally invasive technology were invited to discuss the development of minimally invasive technology as well as share their experience in minimally invasive surgeries. MicroPort® Orthopedics displayed its joint, spine and trauma product lines to demonstrate its branding ideology that "the Patient Always Comes First".
In this conference, MicroPort® Orthopedics displayed its Medial Pivot knee system, which caught wide attention from the attendees with its unique design. MicroPort® Orthopedics Medial Pivot knee was launched in the US in 1998 with around 20 years' clinical history. Up to date, nearly 600,000 Medial Pivot knees have been implanted globally. The Knee has published a study evaluating long-term clinical and radiographic outcomes of the Medial-Pivot Knee System. The results demonstrate excellent clinical outcomes for both satisfaction (95%) and survivorship (98.8%) at 17 years. MicroPort® Orthopedics SuperPath® Micro-posterior Total Hip Arthroplasty ("SuperPath®") also draw public attention with its "full function, faster" feature. As the world's first total hip arthroplasty minimally invasive technique that facilitates a faster return to function for patients, SuperPath® causes incision as little as a 3-inch and ensures the maximum protection of soft tissue, leading to fewer post-operative restrictions, faster return to function, and improved satisfaction for patients. Patients can walk as early as four hours after surgery. Recently a 103-year-old patient successfully received SuperPath® surgery in Zhengjiang First People's Hospital, which helped him to stand on his own feet the same day after the surgery. He is the oldest patient to be effectively treated by SuperPath® surgery in China.
MicroPort® Orthopedics also displayed its spine and trauma products including Wiltrom Spinal Fixation System ("Wiltrom") and Bicera Bone Graft Substitute in its booth. Wiltrom attracted wide attention with its unique guiding pin and guiding instruments. Through interpretations and demonstrations, MicroPort® Orthopedics showcased the advantages of Wiltrom. Some experts spoke highly of the delicate design of Wiltrom, as its matching instrument and sleeves can meet various clinical needs and optimize surgical incision, offering better solution for patients. Meanwhile, MicroPort® Orthopedics also showcased Piscis™ Lumbar & Thoracic Fusion Device, Takin™ Spinal Posterior Fixation System, and Bicera Bone Graft Substitute to visitors, to demonstrate its excellent product offering and lay a solid foundation for future market development.
During the conference, several senior orthopedic experts, including Professor Yan Wang of Chinese PLA General Hospital, visited MicroPort® Orthopedics booth and had in depth discussion with MicroPort® COO Glendy Wang and President of MicroPort® Orthopedics China Zixin Weng regarding product R&D and market development. MicroPort® Orthopedics will continue to take advantage of such conferences to enhance the communication with physicians and keep improving its products based on their clinical needs, and thereby benefit more surgeons and patients.